Spironolactone Tablet, Coated
Product Images NDC 72789-290

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72789-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789290 Label (72789290)

72789290 Label (72789290)
Label for Spironolactone Tablets USP 25 mg oral coated tablets, containing 30 tablets per container. The product is marketed and packaged by PD-Rx Pharmaceuticals, Inc. and manufactured by Oxford Pharmaceuticals, LLC. The label includes storage instructions and a barcode, with a note that the product is for prescription use only (Rx Only).*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A survival probability Kaplan-Meier curve comparing Spironolactone versus placebo over 48 months. The y-axis shows probability, and the x-axis shows time in months. The Spironolactone group (n=822) has a higher survival probability over time compared to the placebo group (n=841). The log-rank test shows a significant difference with p < 0.001.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing Spironolactone versus placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4, with markers indicating whether Spironolactone or placebo performed better.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure of spironolactone, showing its molecular arrangement with characteristic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.